| 000 | 00775naa a2200241 i 4500 | ||
|---|---|---|---|
| 001 | 79003 | ||
| 003 | ES-MaBCM | ||
| 005 | 20241016120626.0 | ||
| 008 | 011114s2001 gbr 000 0 eng d | ||
| 021 | _axx | ||
| 035 | _a(OCoLC)1365147465 | ||
| 040 | _cES-MaBCM | ||
| 041 | 0 | _aeng | |
| 043 | _agbr | ||
| 110 | 1 |
_aGran Bretaña _952053 _bDepartment of Health |
|
| 245 | 1 | 0 |
_aGenetics and insurance _b: Government response to the report from the House of Commons Science and Technology Committee _cDepartment of Health |
| 650 | 7 |
_aProtección del consumidor _958234 |
|
| 650 | 2 | 7 |
_aGenética _958800 |
| 650 | 2 | 7 |
_aSeguro _960212 |
| 651 | 0 |
_aGran Bretaña _9124676 |
|
| 773 | 0 |
_aEn: _tCm _dLondon : 2001 _w104537 _gno. 5286, Oct., p. 1-14. - Loc. REF.66 |
|
| 942 | _cAREV | ||
| 999 |
_c79003 _d79003 |
||